Literature DB >> 8101884

SCH 23390 equivalently, but YM-09151-2 differentially reduces the stimulant effects of methamphetamine, MK-801 and ketamine: assessment by discrete shuttle avoidance in mice.

H Kuribara1, Y Uchihashi.   

Abstract

The inhibitory actions of the selective dopamine D1-and D2-antagonists SCH 23390 and YM-09151-2, respectively, on the mouse's discrete shuttle avoidance were almost equipotent at doses ranging from 0.01-0.1 mg/kg. SCH 23390 reduced the stimulant action of methamphetamine (0.5 mg/kg), MK-801 (0.1 mg/kg) and ketamine (10 mg/kg) with a similar potency. YM-09151-2 also antagonized the actions of these drugs, with the following order of effectiveness: ketamine > MK-801 > methamphetamine. The present results indicate that methamphetamine, MK-801 and ketamine have different characteristics of CNS stimulant action through dopamine D2-receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101884     DOI: 10.1254/jjp.62.111

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  4 in total

1.  D1 and D2 specific dopamine antagonist modulate the caudate nucleus neuronal responses to chronic methylphenidate exposure.

Authors:  Sidish Venkataraman; Catherine Claussen; Nachum Dafny
Journal:  J Neural Transm (Vienna)       Date:  2016-11-16       Impact factor: 3.575

2.  MK801-induced locomotor activity in preweanling and adolescent male and female rats: role of the dopamine and serotonin systems.

Authors:  Sanders A McDougall; Matthew G Apodaca; Ginny I Park; Angie Teran; Timothy J Baum; Nazaret R Montejano
Journal:  Psychopharmacology (Berl)       Date:  2020-05-22       Impact factor: 4.530

3.  Role of adenosine receptor subtypes in methamphetamine reward and reinforcement.

Authors:  Kevin A Kavanagh; Drew C Schreiner; Sophia C Levis; Casey E O'Neill; Ryan K Bachtell
Journal:  Neuropharmacology       Date:  2014-10-06       Impact factor: 5.250

4.  Single exposure of dopamine D1 antagonist prevents and D2 antagonist attenuates methylphenidate effect.

Authors:  Catherine M Claussen; Lindsey J Witte; Nachum Dafny
Journal:  J Exp Pharmacol       Date:  2015-04-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.